期刊文献+

不同激光设备不同方案治疗甲真菌病的疗效评估 被引量:4

The efficacies of different laser devices and treatment plans for onychomycosis
原文传递
导出
摘要 目的:应用不同设备不同方案评估激光治疗甲真菌病的疗效差异。方法:通过回顾性研究,观察2011—2014年北京友谊医院皮肤科门诊应用不同的激光设备对182例甲真菌病患者进行不同次数不同方案治疗后的疗效差异。Pinpointe^(TM) Footlaser^(TM)长脉宽Nd∶YAG1 064 nm激光(Laser M)治疗102例,分为4次治疗组、8次治疗组及12次治疗组;欧洲之星^(TM)靓甲^(TM) Nd:YAG1 064 nm长脉宽激光(Laser S)治疗59例,分为追加治疗组及8次治疗组;奇致^(TM)ML-3420型Nd∶YAG1 064 nm脉冲激光(laser N)治疗21例,均为4次治疗。结果:激光M:4次治疗组24周有效率为37.4%,8次治疗组24周有效率为44.0%,12次治疗组24周有效率为55.4%。激光S:追加治疗方案24周有效率为39%;8次治疗方案24周有效率62.5%。激光N:4次治疗方案24周有效率为52.6%。结论:3种激光设备治疗甲真菌病均有显著效果,且无不良反应;同一激光设备增加治疗次数可以提高有效率;相同的治疗方案,不同的激光治疗有效率有一定的差异,可能与医师操作手法及参数选择有关;治疗间隔不宜过长,应该在真菌恢复生长能力之前或增长至治病数量之前予以巩固治疗;轻中度甲真菌病患者或者病甲数目较少或患者有基础疾病伴有肝肾功能不良者可单纯选择激光治疗,重度甲真菌病或是病甲数目较多的患者应考虑药物和激光联合治疗。 Objective: To determine the efficacies of different lasers and treatment plans for onychomycosis. Methods: The efficaeies of different lasers and treatment plans for onyehomycosis were retrospectively analyzed in 182 outpatients from the department of Beijng Friendship hospital from 2011 to 2014. 102 patients were treated with Pinpointe Footlaser long-pulse Nd :YAG 1 064 nm laser(laser M) for 4, 8 or 12 times, respectively, 59 patients were treated with Dualis SP [[ Nd:YAG/Er: YAG laser System (laser S) for 8 times with or without additional treatment once monthly for 4 months. The rest 21 patients were given 4 treatments with QizhiTM ML-3420 Nd:YAG1 064 nm pulsed laser (laser N). The efficacy was evaluated 24 weeks after the last treatment. Results: In patients treated with Laser M, the effective rates after 4, 8 and 12 treatments were 37.4%, 44.0%, and 55.4%, respectively. The effective rates after Laser S treatment for 8 times with or without additional 4-month treatment were 39% and 62.5%, respectively while Laser N treatment alone induced 52.6% of effective rates after 4 treat- ments. Conclusions: 1. All three lasers are effective and safe for onyehomycosis, 2. The effective rates are associated with the number of treatments, 3. The effective rates vary with the types of laser possibly due to the differences in operating proce- dures between physicians, 4. Treatment interval time should not be too long in order to prevent recurrence, 5. Patients with mild-to-moderate onychomyeosis or a fewer nails involved, or patients with dysfunction of liver and kidney should be treated with laser alone. Combination of drug and laser should be given to patients with severe onyehomyeosis or many nails involved.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2016年第1期15-19,共5页 Journal of Clinical Dermatology
基金 国家自然基金(81301385)资助项目 首都卫生发展科研专项项目(2011-1003-03)
关键词 甲真菌病 Nd:YAG1064nm激光 onychomycosis 1 064 nm Nd : YAG laser
  • 相关文献

参考文献13

  • 1Gupta AK, De Doncker P, Scher RK, et al. Itraconazole for the treatment of onychomycosis[J]. Int J Dermatol, 1998, 37(4): 303-308.
  • 2Havu V, Brandt H, Heikkila H, et al. Adouble-blindrandomised study comparing itraeonazole pulse therapy with eontinuousdosing for the treatment of toe-nail onyehomyeosis [J]. Br J Dermatol, 1997, 136(2): 230-234.
  • 3谭方舒,杨崇艳,张宏.特比萘芬与伊曲康唑治疗甲真菌病疗效的Meta分析[J].中国皮肤性病学杂志,2010,24(11):989-991. 被引量:10
  • 4Sotiriou E, Koussidou T, Pat~tsi A, et al. 5-Aminolevulinic acid-photodynamic treatment for dermatophytic tinea pedis of in- terdigital type: a small clinical study[J]. J Eur Acad Dermatol- Venereol, 2009, 23(2): 203-204.
  • 5Sotiriou E, Panagiotidou D, Ioannides D. 5-Aminolevulininicacid photodynamic therapy treatment for tineacruris caused by Tri- chophytonrubrum: report of 10 cases[J]. J Eur Acad Dermatol- Venereol, 2009, 23(3): 341-342.
  • 6Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, et al. Photody- namic therapy for distaland lateral subungual toenail onychomyco- sis caused byTrichophytonrubrum: preliminary results of a single- centreopen trial[J]. Acta DermVenereol, 2010, 90(2): 216-217.
  • 7Ledon JA, Savas J, Franca K, et al. Laser and light therapy for onychomyeosis: a systematic review[J], lasers Med Sei, 2014, 29 (2): 823-829.
  • 8Borovoy M, Traey M. Noninvasive CO2 laser fenestration im- proves treatment of onyehomyeosis[J]. Clin Laser Mon, 1992, 10 (8): 123-124.
  • 9Landsman AS, Robbins AH, Angelinl PF, et aL Treatment ofmild, moderate, and severe onychomycosis using 870- and 930- nm light exposure[J]. J Am Podiatr Med Assoc, 2010, 100(3): 166-177.
  • 10Meral G, Tasar F, Kocagoz S, et al. Factor affecting the an- tibacterial effects of NdYAG laser in vivo[J]. Lasers Surg Med, 2003, 32(3): 197-202.

二级参考文献18

  • 1Sigurgeirsson B,Olafsson JH,Steinsson JB,et al.Long-term effectivehess of treatment with terbinafine vs itraconazole in onychomycosis:a 5year blinded prospective follow-up study[J].Arch Dermatol,2002,138(3):353-357.
  • 2Evans EG,Sigurgeirsson B.Double-blind,randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis[J].BMJ,1999,318(7190):1031-1035.
  • 3Degreef H,del Palacio A,Mygind S,et al.Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis[J].Acta Derm Venereol,1999,79(3):221-223.
  • 4De Backer M,De Vroey C,Lesaffre E,et al.Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes:adouble-blind comparative trial of tebinafine 250mg/day versus Itraconazole 200mg/day[J].J Am Acad Dermatol,1998,38(5 Pt 3):57-63.
  • 5Honeyman J,Talarico F,Arruda LH,et al.Itraconazole versus terbinafine (LAMISIL):which is better for the treatment of enychomycosis?[J].J Eur Acad Dermatol Venereol,1997,9(3):215-221.
  • 6Braudgam M,Nolting S,Schopf RE,et al.Randomized double-blind comparison of terbinafine and itraconazole for treatrment of toenail tinea infection[J].BMJ,1995,311(7010):919-922.
  • 7Gupta AK,Jain HC,Lynde CW,et al.Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices:a multicenter Canadian survey of 15,000 patiantsLJ].J Am Acod Dermatol,2000,43(2 Pt 1):244-248.
  • 8Sigurgeirsson B,Steingrinosson O,Svein-sdottir S.Prevalence of onychomycosis in Iceland:a population based study[J].Acta Derm Venereol,2002,82 (6):467-469.
  • 9Sigurgeirsson B,Steingrinosson O.Risk factors associated with onychomycosis[J].J Eur Acad Dermatel,Venereal,2004,18 (1):48-51.
  • 10Levy LA.Epidemiology of onychomycosis in special-risk populations[J].J Podiatr Med Assoc,1997,87(12):546-550.

共引文献9

同被引文献32

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部